๐—–๐—ผ๐—บ๐—ฝ๐—น๐—ฒ๐˜๐—ฒ ๐—ฃ๐——๐—™ ๐—š๐˜‚๐—ถ๐—ฑ๐—ฒ ๐˜๐—ผ ๐—–๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ผ๐—บ๐—ฒ๐˜๐—ฎ๐—ฏ๐—ผ๐—น๐—ถ๐—ฐ ๐——๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ๐˜€

Cardiometabolic disease is characterized by a group of abnormalities and symptoms that raise the risk of individuals developing cardiovascular disease. Hypertension, obesity, insulin resistance, dyslipidemia, poor cholesterol profile (LDL), and glucose tolerance are a few symptoms of cardiometabolic diseases. Individuals suffering from cardiometabolic syndrome are prone to many other life-threatening diseases, such as type 2 diabetes, stroke, coronary artery disease (CAD), and cardiovascular disease (CVD).

๐——๐—ผ๐˜„๐—ป๐—น๐—ผ๐—ฎ๐—ฑ ๐—ฎ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—ฃ๐——๐—™ ๐—›๐—ฒ๐—ฟ๐—ฒ @ https://www.theinsightpartners.com/sample/TIPRE00025374

Cardiometabolic Diseases Market: Competitive Landscape and Key Developments: Eli Lilly and Company Bayer AG Arrowhead Pharmaceuticals, Inc Novartis AG Boehringer Ingelheim International GmbH Novo Nordisk A/S AstraZeneca Alnylam Pharmaceuticals, Inc. Cardax, Inc

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person:ย Ankit Mathur

E-mail:ย [email protected]

Phone:ย +1-646-491-9876

 

Scroll to Top